Back to Search
Start Over
Pharmacokinetics of a single dose of fulvestrant prolonged-release intramuscular injection in postmenopausal women awaiting surgery for primary breast cancer
- Source :
-
Clinical Therapeutics . May2003, Vol. 25 Issue 5, p1440. 13p. - Publication Year :
- 2003
-
Abstract
- <B>Objective:</B> The aim of this study was to describe the pharmacokinetics of 3 different single doses of fulvestrant—a new estrogen receptor (ER) antagonist that downregulates the ER with no known agonist effects—administered as a prolonged-release IM formulation.<B>Methods:</B> Pharmacokinetic data were obtained in a randomized, partially blinded, placebo-controlled, parallel-group, Phase I/II multicenter trial involving postmenopausal women with primary breast cancer (clinical stages T1–T3, with tumors that were ER positive or of unknown ER status) awaiting curative-intent surgery. Patients received either IM fulvestrant (50, 125, or 250 mg), oral tamoxifen (20 mg, once daily), or oral placebo (once daily). Treatment started 2 to 3 weeks before surgery and blood was taken at various times up to 12 weeks after fulvestrant administration to assess pharmacokinetic variables.<B>Results:</B> A total of 200 patients entered the trial, of whom 58 took part in the pharmacokinetic analysis (50 mg, n = 20; 125 mg, n = 16; 250 mg, n = 22). Following single IM injections of fulvestrant, the median time to maximum concentration was 6.98, 6.98, and 6.96 days in the 50-, 125,- and 250-mg dose groups, respectively, with an overall range of 2 to 19 days). The plasma concentration-time profiles were primarily controlled by the rate of absorption from the injection site; post-peak plasma concentrations declined over time and were measurable up to 84 days after administration of fulvestrant 125 and 250 mg. Plasma [Copyright &y& Elsevier]
- Subjects :
- *PHARMACOKINETICS
*ESTROGEN
*CLINICAL trials
Subjects
Details
- Language :
- English
- ISSN :
- 01492918
- Volume :
- 25
- Issue :
- 5
- Database :
- Academic Search Index
- Journal :
- Clinical Therapeutics
- Publication Type :
- Academic Journal
- Accession number :
- 10233854
- Full Text :
- https://doi.org/10.1016/S0149-2918(03)80131-5